Cabot (CBT)
(Delayed Data from NYSE)
$109.02 USD
+1.19 (1.10%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $109.06 +0.04 (0.04%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$109.02 USD
+1.19 (1.10%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $109.06 +0.04 (0.04%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Zacks News
L.B. Foster (FSTR) to Post Q3 earnings: What's in Store?
by Zacks Equity Research
L.B. Foster (FSTR) is likely to have gained from improved order activities across its Rail and Construction segments in Q3.
FMC Corp (FMC) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Strong demand for FMC Corp's (FMC) products and benefits of new product launches are likely to get reflected on its Q3 results.
Vale (VALE) Gears Up to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Vale's (VALE) third-quarter results are likely to reflect higher iron ore production and rising iron ore prices.
Coeur Mining (CDE) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Coeur Mining's (CDE) third-quarter results are likely to reflect resumption of operations at Palmarejo, strong results from its three U.S. operations, and higher gold and silver prices.
3 Reasons Why Cabot (CBT) Is a Great Growth Stock
by Zacks Equity Research
Cabot (CBT) possesses solid growth attributes, which could help it handily outperform the market.
Why Is Cabot (CBT) Up 1.1% Since Last Earnings Report?
by Zacks Equity Research
Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cabot (CBT) Misses Earnings and Sales Estimates in Q3
by Zacks Equity Research
Lower volumes, unfavorable product mix and a competitive pricing environment impacts Cabot's (CBT) Performance Chemicals unit in Q3.
New Strong Sell Stocks for August 10th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Earnings Preview: Cabot (CBT) Q3 Earnings Expected to Decline
by Zacks Equity Research
Cabot (CBT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cabot Completes Placement of Air Emission Control Equipment
by Zacks Equity Research
Cabot (CBT) is on course to conclude the project ahead of the EPA-set deadline despite the challenges posed by Hurricane Barry and the COVID-19 pandemic.
Cabot (CBT) Up 43% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cabot (CBT) Amends Credit Facilities to Increase Flexibility
by Zacks Equity Research
Cabot (CBT) expects to increase the maximum leverage ratio to provide additional flexibility beyond the coronavirus outbreak-related stress test scenarios.
Cabot (CBT) Earnings Surpass Estimates in Q2, Sales Miss
by Zacks Equity Research
Cabot (CBT) expects demand to be low in the fiscal third quarter due to the impacts of the coronavirus pandemic.
Cabot (CBT) Beats Q2 Earnings Estimates
by Zacks Equity Research
Cabot (CBT) delivered earnings and revenue surprises of 8.45% and -8.26%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for April 3rd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
Cabot (CBT) Completes Acquisition of SUSN for $115 Million
by Zacks Equity Research
The integration of Cabot's (CBT) portfolio of energy materials and SUSN is expected to create a business that generates sales of around $50 million.
Cabot (CBT) Withdraws FY20 View Amid Coronavirus Pandemic
by Zacks Equity Research
Cabot (CBT) expects financial results to be solid for the fiscal second quarter. However, it is withdrawing the previous financial guidance for fiscal 2020.
Why Is Cabot (CBT) Down 10.9% Since Last Earnings Report?
by Zacks Equity Research
Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Moving Average Crossover Alert: Cabot
by Zacks Equity Research
Cabot Corporation (CBT) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.
Cabot Launches Engineered Elastomer Composites Solutions
by Zacks Equity Research
Cabot's (CBT) E2C solutions are geared to raise the bar in tire performance, while offering tire production efficiencies.
Cabot's (CBT) Earnings and Revenues Trail Estimates in Q1
by Zacks Equity Research
Lower volumes hurt Cabot's (CBT) Reinforcement Materials segment in Q1.
Cabot (CBT) Misses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Cabot (CBT) delivered earnings and revenue surprises of -9.21% and -8.40%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Cabot (CBT) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Cabot (CBT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cabot (CBT) to Purchase Shenzhen Sanshun Nano New Materials
by Zacks Equity Research
Cabot (CBT) expects the acquisition to deliver innovative solutions that facilitate better battery performance at an optimized price-to-performance ratio.
Cabot (CBT) Down 8.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.